Secondly, present evidence adds weight and credence to the overall interpretation of in vitro, in vivo and human data that confirms the role of TRAF6/NFκB axis in the regulation of the ability of metastatic breast cancer cells to metastasise, grow in distant tissues, and influence the differentiation of healthy cells such as osteoclasts. Here, NFKB1 is linked to breast carcinoma.